Hold RTX at 80-85% residual with $192 stop and tiered upgrade triggers above $196.87
Maintain 80-85% residual RTX exposure without adding fresh capital at $194.34, where price sits 0.6% above untested 200 SMA support with compressed ATR. The $192 stop protects against binary breakdown while preserving upside participation if 200 SMA holds and momentum repairs. Downside path risk to $185-180 (4.4-4.7%) materially exceeds 3.7% upside to first resistance at $201.68, making fresh capital commitment at this configuration poor risk/reward. The 1.49% dividend yield provides quantified carry floor on the residual position while avoiding both the 9/02 'sell into structural floor attenuation' failure mode and the 9/16 'add at untested support' failure mode that produced -2.8% alpha.
| Position | Action |
|---|---|
| Current position (existing 80-85% residual) | Maintain residual exposure without adding fresh capital |
| Confirmed close below $188 (Bollinger lower band) | Downgrade to Underweight with 15-20% trim |
| Confirmed close above $196.87 (10 EMA) | Deploy 30% of intended new position |
| Confirmed close above $201.68 (Bollinger middle band) | Deploy additional 40% of intended new position |
| Confirmed close above $207 (50 SMA) | Deploy final 30% of intended new position |
RTX presents a compelling risk/reward at the 200 SMA support level with mispriced 38% EPS growth (forward PEG 0.65), accelerating Q2 2026 fundamentals, and imminent buyback resumption—the "HOLD and wait" stance will cost investors 8-12% of the move before confirmation becomes visible.
| Indicator | Value | Signal |
|---|---|---|
| close | $194.34 | neutral |
| close_10_ema | $196.87 | bearish |
| close_50_sma | $207.68 | bearish |
| close_200_sma | $193.11 | neutral |
| rsi | 31.98 | bullish |
| macd | -4.49 | bearish |
| macds | -3.68 | bearish |
| macdh | -0.81 | bullish |
| boll_lb | $188.45 | neutral |
| atr | $3.90 | neutral |
| boll_middle | $201.68 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above $201.68 (Bollinger middle band)
Then: Deploy 40% of intended new position
Forward PEG of 0.65 shows market is mispricing RTX recovery — not premium valuation
↩ rebuts: “bear's 'premium valuation leaves little room for missteps'”
EV: +5.7% to +13.4% (target $215-220 from $194 entry over 6-9 months) · concedes: Bear's technical observation of price below all major MAs is true on the surface; Bear's working capital concern (current ratio 1.01) is technically accurate but reflects backlog conversion investment, not distress; Bear's point that 200 SMA has not yet held is a valid risk — stop placed at $188 daily close
The risk/reward of buying the 200 SMA test is asymmetric to the downside—price closed just $1.23 above the 200 SMA, technical indicators (RSI, MACD, ATR compression) are equally consistent with continuation lower, forward EPS of $7.85 requires all five assumptions to hold simultaneously, and the macro environment has flipped from tailwind to headwind with 96% no-cut probability, making the multiple expansion that powered the 105% gain a source of multiple compression risk instead.
· concedes: Q2 2026 was good: Revenue +14.5% YoY, EPS +29% YoY, net debt down $8B YoY; The 200 SMA test does offer some support probability; Defense backlog is real revenue regardless of multiple compression; Existing holders should not panic-sell at this level
→ vs conservative: Calls 'asymmetric downside risk' framing 'lazy math'—the 200 SMA at $193.11 is only 0.6% below current price with limited downside and multiple expansion points above
→ vs conservative: Disputes cherry-picking charge—claims conservative ignored actual risk/reward at current level by using most pessimistic upside target
→ vs conservative: Rejects 'wait for confirmation' approach as 'analysis paralysis' that turns great setups into missed trades; by the time confirmation arrives at $198, risk/reward collapses from 3-to-1 to 1.5-to-1
→ vs conservative: Argues the 14% pullback from $226 to $194 IS the multiple compression playing out in real time—using current rates as a reason to stay out at major support is 'buying fear after the damage is done'
→ vs conservative: Dismisses Polymarket's 96% probability of no 2026 cuts and Cramer's compression warning as already priced in—'You don't refuse to catch a falling knife when it's already embedded in the cutting board'
→ vs conservative: Challenges the notion that RSI at 31.98 is 'precarious'—argues it represents 'energy building' rather than danger
→ vs conservative: Notes technical report itself calls this a coiled-spring setup, then questions why conservative analyst pivots to waiting for confirmation
→ vs conservative: Frames silent Reddit sentiment as a 'gift' with no crowded trade to unwind, not a risk signal
| boll_ub | $214.91 | neutral |
Support: 193.11 · 188.45 · 185.76 | Resistance: 196.87 · 201.68 · 207.68
RTX is at a binary technical setup, testing the critical 200-day SMA support at $193.11 after a 14% drawdown from August peak. The trend stack is bearish with price below all major moving averages, but momentum is decelerating (MACD histogram improving from -2.46 to -0.81) and RSI approaching oversold (31.98). Volatility has compressed 31% (ATR $3.90 from $5.66), creating a coiled-spring setup that could trigger a sharp reversal if $193 holds. HOLD rating reflects a wait-and-see stance: existing holders should tighten stops below $193, while new positions require either confirmed 200 SMA defense or decisive breakdown.
Market Cap
$261.9 billion
Beta
0.287
52-Week Range
$155.64 – $226.88
P/E (TTM)
34.2x
Forward P/E
24.8x
PEG Ratio
2.25
P/B
3.95x
EV/EBITDA
~17.8x
Revenue (TTM)
$93.5B
Gross Profit (TTM)
$19.0B
EBITDA (TTM)
$15.9B
Operating Margin
12.7%
Net Income (TTM)
$7.74B
ROE
12.3%
ROA
4.2%
Total Assets
$173.97B
Total Liabilities
$105.83B
Total Equity
$66.38B
Cash & Equivalents
$8.31B
Total Debt
$38.86B
Long-Term Debt
$31.86B
Net Debt
$29.08B
Debt/Equity
~57%
Current Ratio
1.011
Inventory
$14.41B
Receivables
$32.92B
Goodwill & Intangibles
$83.97B
Operating Cash Flow (TTM)
~$14.2B
Free Cash Flow (TTM)
$9.88B
CapEx (TTM)
~$3.2B
Dividends (TTM)
~$3.8B
EPS (TTM)
$5.68
Forward EPS
$7.85
Dividend Yield
1.51%
Book Value/Share
$49.25
Revenue YoY (Q2 2026)
+14.5%
EBITDA YoY (Q2 2026)
+18%
EPS YoY (Q2 2026)
+29%
Q2 2026 Revenue
$24.7B
Q2 2026 Gross Profit
$5.13B
Q2 2026 Operating Income
$2.81B
Q2 2026 EBITDA
$4.25B
Q2 2026 Net Income
$2.14B
Q2 2026 Diluted EPS
$1.57
50-Day MA
$208.05
200-Day MA
$194.17
Strengths
Concerns
RTX Corporation is a high-quality, mega-cap ($261.9B) aerospace & defense franchise with strong secular tailwinds from defense spending and commercial aerospace recovery. The company demonstrates accelerating fundamentals: Q2 2026 revenue of $24.7B (+14.5% YoY), EBITDA expansion of 18% YoY, and EPS growth of 29% YoY to $1.57, supported by robust TTM free cash flow of $9.88B and aggressive deleveraging that reduced net debt by $8.1B in 12 months. However, the premium valuation (P/E 34.2x, PEG 2.25, Forward P/E 24.8x) limits upside surprise unless forward EPS growth of ~38% materializes, with key risks including GTF aftermarket execution, working capital tightness (current ratio 1.01), and government budget sensitivity, though a pullback toward the 200-day MA (~$194) would offer a more attractive risk/reward entry point for long positions.
Macro: Global rate posture is tightening, not loosening: Polymarket shows 96% probability of zero Fed cuts in 2026 ($8.47M volume); ECB hike odds at 41% (+7pp w/w), BoE hike at 59% (+12pp w/w); US recession odds by end of 2026 at just 6% (down 3pp). The single dominant macro variable is higher-for-longer rates compressing growth/defense multiples. Note: FRED macro data unavailable due to missing API key; macro picture constructed from news flow and prediction markets.